Gerdi Strydom
MD Valid Insight
With over 20 years of leadership experience in the biopharmaceutical industry, Gerdi Strydom is a seasoned expert in market access strategy, pricing, and payer evidence development. Currently serving as the Managing Director at Valid Insight, Gerdi’s career has been defined by her ability to craft and execute integrated value and access strategies that drive the successful commercialisation and reimbursement of innovative therapies across diverse therapeutic areas, including oncology, immunology, rare diseases, and vaccines.
Gerdi’s strategic insights are deeply rooted in her extensive experience in both consulting and leading roles within major biopharmaceutical companies such as Pfizer and Roche. Her proven track record of translating complex market challenges into actionable strategies and effectively navigating product development, launch, and commercialisation processes globally, is a testament to her adaptability and strategic capabilities. Her leadership has spanned Europe, Asia, Latin America, Africa, and the Middle East, where she has managed intricate pricing negotiations to optimise product value.
Gerdi’s approach is underpinned by a steadfast commitment to ensuring that innovative therapies reach the patients who need them most. Her focus on maximising market potential and aligning with payer expectations underscores her strategic approach and dedication to the industry.
